Cash And Equivalent 更改
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
ALKERMES USD 647.71M 18.08M 2023-09
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Biogen USD 1.05B 1.24B 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Cara Therapeutics USD 62.88M 4.63M 2023-09
Corcept Therapeutics USD 425.4M 313.6M 2023-12
Cytokinetics USD 113.02M 13.33M 2023-12
Eisai JPY 281.45B 12.15B 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Intra Cellular Therapies USD 147.77M 48.36M 2023-12
J&J USD 3.5B 497M 2023-09
Marinus Pharmaceuticals USD 140.44M 12.65M 2023-09
Moderna USD 2.91B 25M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Sarepta Therapeutics USD 541.93M 310M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vanda Pharmaceuticals USD 150.03M 204.14M 2023-06
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Acadia Pharmaceuticals 现金及等价物 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.